Latest Whitepapers

Many regulatory guidelines state that cell banks and cultures used in the production of biologics must be tested for mycoplasma. Mycoplasma infections can cause severe problems in manufacturing as these organisms can alter DNA, RNA and modify host cell plasma membrane antigens.

For the very first time since its publication, ACS Reagent Chemicals is now available online in a seamless, searchable database. If you are a producer of pharmaceuticals, download this whitepaper to learn how this invaluable resource can benefit your organization.

Whether you are simply splitting cells as a part of routine cell culture or preparing cell samples for experiments downstream.

Serious infectious disease outbreaks have been an ever-present threat throughout human history and, driven by factors such as increasing globalization, population growth, urbanization and climate change, that threat is increasing.

Safety, accuracy and reliability are paramount in the development and testing of fine and specialty chemicals. Add to that the need for regulatory compliance, and it becomes clear that proper tools are needed.

GeoMx® Human Whole Transcriptome Atlas

Traditional gene expression technologies are unable to capture heterogeneity of the transcriptome with spatial context.

Spatially resolved biology allows researchers to study cells in the context of their tissue microenvironment, enabling a fuller appreciation of cellular function.

Automation, robotics and digital technologies are transforming laboratory processes in life sciences, R&D and manufacturing, and driving a new era in data-focused disease and drug discovery.

Small molecule drugs have formed most pharmaceutical discoveries for over a century, however, approximately 40% of current active pharmaceutical ingredients (APIs) are poorly soluble, along with around 90% of drugs in development.

Flow cytometry has enabled the discovery of varied and nuanced cell types in terms of phenotypic markers and biological functions, but the visible spectrum places limitations on the number of extrinsic parameters that can be assessed.